Global Neurological Biomarkers Market to Grow at A CAGR of 15.48% During The Period 2016-2020

About Neurological Biomarkers

Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are called neurological biomarkers.

Read more at: http://www.researchbeam.com/global-neurological-biomarkers-2016-2020-market

Researchbeam’s analysts forecast the global neurological biomarkers market to grow at a CAGR of 15.48% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global neurological biomarkers market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of neurological biomarkers.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Researchbeam's report, Global Neurological Biomarkers Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Myriad RBM
• Proteome Sciences
• QIAGEN
• Thermo Fisher Scientific

Other prominent vendors
• AbaStar MDx
• Abiant
• Acumen Pharmaceuticals
• Aepodia
• Alseres Pharmaceuticals
• Athena Diagnostics
• Banyan Biomarkers
• Cisbio Bioassays
• Diagenic
• Proteosys
• Psynova Neurotech

Market driver
• Increasing focus toward drug discovery applications
• For a full, detailed list, view our report

Market challenge
• Unmet market needs of effective validation of biomarkers
• For a full, detailed list, view our report

Market trend
• Integrated biology approach will be the key focus area
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Request report sample @ http://www.researchbeam.com/global-neurological-biomarkers-2016-2020-market/enquire-about-report

Table of Contents

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Biomarker assays kits

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis:

PART 06: Market segmentation by indication
• AD
• PD
• ASD
• MS

PART 07: Market segmentation by application
• Genomics-based biomarkers
• Proteomics-based biomarkers
• Metabolomics-based biomarkers
• Imaging-based biomarkers
• Emerging application areas
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax: +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com/